The success of Viagra initially fueled a boom for major pharmaceutical companies, nevertheless recent changes present a uncertain outlook for shareholders. Lower-cost alternatives are eroding revenue, and ongoing https://charliedptj431565.ssnblog.com/39821064/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play